aluates Reports

$ 0.0

Automative

Global Hemophilia AAV Gene Therapy Market Research Report 2024

Published Date: November 2024

Report Code: QYRE-Auto-12Z18627

BUY CHAPTERS

Global Hemophilia AAV Gene Therapy Market Research Report 2024

Code: QYRE-Auto-12Z18627

Report

November 2024

Pages:64

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

BioMarin (Roctavian)

CSL/uniQure (Hemgenix&Glybera)

Pfizer Inc

Hemophilia AAV Gene Therapy Market Size

The global market for Hemophilia AAV Gene Therapy was valued at US$ 13.1 million in the year 2023 and is projected to reach a revised size of US$ 189 million by 2030, growing at a CAGR of 38.6% during the forecast period.

Hemophilia AAV Gene Therapy Market

Hemophilia AAV gene therapy is an innovative treatment approach for hemophilia using adeno - associated virus (AAV) as a vector to transfer normal clotting factor genes into the bodies of hemophilia patients to correct the genetic defect and thus treat the disease. Hemophilia is a hereditary bleeding disorder, mainly including hemophilia A (deficiency of clotting factor VIII) and hemophilia B (deficiency of clotting factor IX).

North American market for Hemophilia AAV Gene Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Hemophilia AAV Gene Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Hemophilia AAV Gene Therapy in Hemophilia A is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Hemophilia AAV Gene Therapy include BioMarin (Roctavian), CSL/uniQure (Hemgenix&Glybera), Pfizer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Hemophilia AAV Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemophilia AAV Gene Therapy.

The Hemophilia AAV Gene Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemophilia AAV Gene Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hemophilia AAV Gene Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Hemophilia AAV Gene Therapy Market Report

Report Metric	Details
Report Name	Hemophilia AAV Gene Therapy Market
Accounted market size in year	US$ 13.1 million
Forecasted market size in 2030	US$ 189 million
CAGR	38.6%
Base Year	year
Forecasted years	2024 - 2030
Segment by Type	AVV5 Vector AAVrh74 Vector
Segment by Application	Hemophilia A Hemophilia B
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	BioMarin (Roctavian), CSL/uniQure (Hemgenix&Glybera), Pfizer
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hemophilia AAV Gene Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Hemophilia AAV Gene Therapy Market growing?

Ans: The Hemophilia AAV Gene Therapy Market witnessing a CAGR of 38.6% during the forecast period 2024-2030.

What is the Hemophilia AAV Gene Therapy Market size in 2030?

Ans: The Hemophilia AAV Gene Therapy Market size in 2030 will be US$ 189 million.

Who are the main players in the Hemophilia AAV Gene Therapy Market report?

Ans: The main players in the Hemophilia AAV Gene Therapy Market are BioMarin (Roctavian), CSL/uniQure (Hemgenix&Glybera), Pfizer

What are the Application segmentation covered in the Hemophilia AAV Gene Therapy Market report?

Ans: The Applications covered in the Hemophilia AAV Gene Therapy Market report are Hemophilia A, Hemophilia B

What are the Type segmentation covered in the Hemophilia AAV Gene Therapy Market report?

Ans: The Types covered in the Hemophilia AAV Gene Therapy Market report are AVV5 Vector, AAVrh74 Vector

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Hemophilia AAV Gene Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 AVV5 Vector

1.2.3 AAVrh74 Vector

1.3 Market by Application

1.3.1 Global Hemophilia AAV Gene Therapy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hemophilia A

1.3.3 Hemophilia B

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Hemophilia AAV Gene Therapy Market Perspective (2019-2030)

2.2 Global Hemophilia AAV Gene Therapy Growth Trends by Region

2.2.1 Global Hemophilia AAV Gene Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Hemophilia AAV Gene Therapy Historic Market Size by Region (2019-2024)

2.2.3 Hemophilia AAV Gene Therapy Forecasted Market Size by Region (2025-2030)

2.3 Hemophilia AAV Gene Therapy Market Dynamics

2.3.1 Hemophilia AAV Gene Therapy Industry Trends

2.3.2 Hemophilia AAV Gene Therapy Market Drivers

2.3.3 Hemophilia AAV Gene Therapy Market Challenges

2.3.4 Hemophilia AAV Gene Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Hemophilia AAV Gene Therapy Players by Revenue

3.1.1 Global Top Hemophilia AAV Gene Therapy Players by Revenue (2019-2024)

3.1.2 Global Hemophilia AAV Gene Therapy Revenue Market Share by Players (2019-2024)

3.2 Global Hemophilia AAV Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Hemophilia AAV Gene Therapy Revenue

3.4 Global Hemophilia AAV Gene Therapy Market Concentration Ratio

3.4.1 Global Hemophilia AAV Gene Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Hemophilia AAV Gene Therapy Revenue in 2023

3.5 Global Key Players of Hemophilia AAV Gene Therapy Head office and Area Served

3.6 Global Key Players of Hemophilia AAV Gene Therapy, Product and Application

3.7 Global Key Players of Hemophilia AAV Gene Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Hemophilia AAV Gene Therapy Breakdown Data by Type

4.1 Global Hemophilia AAV Gene Therapy Historic Market Size by Type (2019-2024)

4.2 Global Hemophilia AAV Gene Therapy Forecasted Market Size by Type (2025-2030)

5 Hemophilia AAV Gene Therapy Breakdown Data by Application

5.1 Global Hemophilia AAV Gene Therapy Historic Market Size by Application (2019-2024)

5.2 Global Hemophilia AAV Gene Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Hemophilia AAV Gene Therapy Market Size (2019-2030)

6.2 North America Hemophilia AAV Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Hemophilia AAV Gene Therapy Market Size by Country (2019-2024)

6.4 North America Hemophilia AAV Gene Therapy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Hemophilia AAV Gene Therapy Market Size (2019-2030)

7.2 Europe Hemophilia AAV Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Hemophilia AAV Gene Therapy Market Size by Country (2019-2024)

7.4 Europe Hemophilia AAV Gene Therapy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Hemophilia AAV Gene Therapy Market Size (2019-2030)

8.2 Asia-Pacific Hemophilia AAV Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Hemophilia AAV Gene Therapy Market Size by Region (2019-2024)

8.4 Asia-Pacific Hemophilia AAV Gene Therapy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Hemophilia AAV Gene Therapy Market Size (2019-2030)

9.2 Latin America Hemophilia AAV Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Hemophilia AAV Gene Therapy Market Size by Country (2019-2024)

9.4 Latin America Hemophilia AAV Gene Therapy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Hemophilia AAV Gene Therapy Market Size (2019-2030)

10.2 Middle East & Africa Hemophilia AAV Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Hemophilia AAV Gene Therapy Market Size by Country (2019-2024)

10.4 Middle East & Africa Hemophilia AAV Gene Therapy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 BioMarin (Roctavian)

11.1.1 BioMarin (Roctavian) Company Details

11.1.2 BioMarin (Roctavian) Business Overview

11.1.3 BioMarin (Roctavian) Hemophilia AAV Gene Therapy Introduction

11.1.4 BioMarin (Roctavian) Revenue in Hemophilia AAV Gene Therapy Business (2019-2024)

11.1.5 BioMarin (Roctavian) Recent Development

11.2 CSL/uniQure (Hemgenix&Glybera)

11.2.1 CSL/uniQure (Hemgenix&Glybera) Company Details

11.2.2 CSL/uniQure (Hemgenix&Glybera) Business Overview

11.2.3 CSL/uniQure (Hemgenix&Glybera) Hemophilia AAV Gene Therapy Introduction

11.2.4 CSL/uniQure (Hemgenix&Glybera) Revenue in Hemophilia AAV Gene Therapy Business (2019-2024)

11.2.5 CSL/uniQure (Hemgenix&Glybera) Recent Development

11.3 Pfizer

11.3.1 Pfizer Company Details

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Hemophilia AAV Gene Therapy Introduction

11.3.4 Pfizer Revenue in Hemophilia AAV Gene Therapy Business (2019-2024)

11.3.5 Pfizer Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

BioMarin (Roctavian)

CSL/uniQure (Hemgenix&Glybera)

Pfizer Inc

List of Tables

Table 1. Global Hemophilia AAV Gene Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of AVV5 Vector

Table 3. Key Players of AAVrh74 Vector

Table 4. Global Hemophilia AAV Gene Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Hemophilia AAV Gene Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Hemophilia AAV Gene Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Hemophilia AAV Gene Therapy Market Share by Region (2019-2024)

Table 8. Global Hemophilia AAV Gene Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Hemophilia AAV Gene Therapy Market Share by Region (2025-2030)

Table 10. Hemophilia AAV Gene Therapy Market Trends

Table 11. Hemophilia AAV Gene Therapy Market Drivers

Table 12. Hemophilia AAV Gene Therapy Market Challenges

Table 13. Hemophilia AAV Gene Therapy Market Restraints

Table 14. Global Hemophilia AAV Gene Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Hemophilia AAV Gene Therapy Market Share by Players (2019-2024)

Table 16. Global Top Hemophilia AAV Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemophilia AAV Gene Therapy as of 2023)

Table 17. Ranking of Global Top Hemophilia AAV Gene Therapy Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Hemophilia AAV Gene Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Hemophilia AAV Gene Therapy, Headquarters and Area Served

Table 20. Global Key Players of Hemophilia AAV Gene Therapy, Product and Application

Table 21. Global Key Players of Hemophilia AAV Gene Therapy, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Hemophilia AAV Gene Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Hemophilia AAV Gene Therapy Revenue Market Share by Type (2019-2024)

Table 25. Global Hemophilia AAV Gene Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Hemophilia AAV Gene Therapy Revenue Market Share by Type (2025-2030)

Table 27. Global Hemophilia AAV Gene Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Hemophilia AAV Gene Therapy Revenue Market Share by Application (2019-2024)

Table 29. Global Hemophilia AAV Gene Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Hemophilia AAV Gene Therapy Revenue Market Share by Application (2025-2030)

Table 31. North America Hemophilia AAV Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Hemophilia AAV Gene Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Hemophilia AAV Gene Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Hemophilia AAV Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Hemophilia AAV Gene Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Hemophilia AAV Gene Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Hemophilia AAV Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Hemophilia AAV Gene Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Hemophilia AAV Gene Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Hemophilia AAV Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Hemophilia AAV Gene Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Hemophilia AAV Gene Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Hemophilia AAV Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Hemophilia AAV Gene Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Hemophilia AAV Gene Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 46. BioMarin (Roctavian) Company Details

Table 47. BioMarin (Roctavian) Business Overview

Table 48. BioMarin (Roctavian) Hemophilia AAV Gene Therapy Product

Table 49. BioMarin (Roctavian) Revenue in Hemophilia AAV Gene Therapy Business (2019-2024) & (US$ Million)

Table 50. BioMarin (Roctavian) Recent Development

Table 51. CSL/uniQure (Hemgenix&Glybera) Company Details

Table 52. CSL/uniQure (Hemgenix&Glybera) Business Overview

Table 53. CSL/uniQure (Hemgenix&Glybera) Hemophilia AAV Gene Therapy Product

Table 54. CSL/uniQure (Hemgenix&Glybera) Revenue in Hemophilia AAV Gene Therapy Business (2019-2024) & (US$ Million)

Table 55. CSL/uniQure (Hemgenix&Glybera) Recent Development

Table 56. Pfizer Company Details

Table 57. Pfizer Business Overview

Table 58. Pfizer Hemophilia AAV Gene Therapy Product

Table 59. Pfizer Revenue in Hemophilia AAV Gene Therapy Business (2019-2024) & (US$ Million)

Table 60. Pfizer Recent Development

Table 61. Research Programs/Design for This Report

Table 62. Key Data Information from Secondary Sources

Table 63. Key Data Information from Primary Sources

Table 64. Authors List of This Report

List of Figures

Figure 1. Hemophilia AAV Gene Therapy Picture

Figure 2. Global Hemophilia AAV Gene Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Hemophilia AAV Gene Therapy Market Share by Type: 2023 VS 2030

Figure 4. AVV5 Vector Features

Figure 5. AAVrh74 Vector Features

Figure 6. Global Hemophilia AAV Gene Therapy Market Size by Application (2024-2030) & (US$ Million)

Figure 7. Global Hemophilia AAV Gene Therapy Market Share by Application: 2023 VS 2030

Figure 8. Hemophilia A Case Studies

Figure 9. Hemophilia B Case Studies

Figure 10. Hemophilia AAV Gene Therapy Report Years Considered

Figure 11. Global Hemophilia AAV Gene Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Hemophilia AAV Gene Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Hemophilia AAV Gene Therapy Market Share by Region: 2023 VS 2030

Figure 14. Global Hemophilia AAV Gene Therapy Market Share by Players in 2023

Figure 15. Global Top Hemophilia AAV Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemophilia AAV Gene Therapy as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Hemophilia AAV Gene Therapy Revenue in 2023

Figure 17. North America Hemophilia AAV Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Hemophilia AAV Gene Therapy Market Share by Country (2019-2030)

Figure 19. United States Hemophilia AAV Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Hemophilia AAV Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Hemophilia AAV Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Hemophilia AAV Gene Therapy Market Share by Country (2019-2030)

Figure 23. Germany Hemophilia AAV Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Hemophilia AAV Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Hemophilia AAV Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Hemophilia AAV Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Hemophilia AAV Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Hemophilia AAV Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Hemophilia AAV Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Hemophilia AAV Gene Therapy Market Share by Region (2019-2030)

Figure 31. China Hemophilia AAV Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Hemophilia AAV Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Hemophilia AAV Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Hemophilia AAV Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Hemophilia AAV Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Hemophilia AAV Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Hemophilia AAV Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Hemophilia AAV Gene Therapy Market Share by Country (2019-2030)

Figure 39. Mexico Hemophilia AAV Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Hemophilia AAV Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Hemophilia AAV Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Hemophilia AAV Gene Therapy Market Share by Country (2019-2030)

Figure 43. Turkey Hemophilia AAV Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Hemophilia AAV Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. UAE Hemophilia AAV Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. BioMarin (Roctavian) Revenue Growth Rate in Hemophilia AAV Gene Therapy Business (2019-2024)

Figure 47. CSL/uniQure (Hemgenix&Glybera) Revenue Growth Rate in Hemophilia AAV Gene Therapy Business (2019-2024)

Figure 48. Pfizer Revenue Growth Rate in Hemophilia AAV Gene Therapy Business (2019-2024)

Figure 49. Bottom-up and Top-down Approaches for This Report

Figure 50. Data Triangulation

Figure 51. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global AAV Vector Gene Therapy Market Research Report 2024

Hemophilia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global AAV based Gene Therapy Products Market Research Report 2024

Global AAV Gene Therapy Injection Market Research Report 2024

Global AAV Vector Based Gene Therapy Drugs Market Research Report 2024

Global AAV Gene Therapy Drugs Market Research Report 2024

Global Ophthalmic AAV Gene Therapy Market Research Report 2024

Global Hemophilia Medication Market Research Report 2024

Adeno Associated Virus AAV Vector Based Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene Therapy Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Human Coagulation Factor VIII Market Research Report 2020

Global Adeno Associated Virus Vectors in Gene Therapy Market Research Report 2025

Global Haemophilia Treatment Market Insights Forecast to 2030

Global Recombinant Antihemophilic Globulin Market Research Report 2024

Global Gene Therapy for Sickle Cell Disease Market Research Report 2024

Recombinant Factor VIII Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Adeno Associated Virus AAV Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hemophilia Treatment Medications Market Research Report 2024

Global Acquired Hemophilia Treatment Market Insights Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-6I13272

Wed May 21 00:00:00 UTC 2025

Add to Cart

Global Neonatal Respiratory Distress Syndrome Treatment Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0L13961

Wed May 21 00:00:00 UTC 2025

Add to Cart

Global Acrocallosal Syndrome Treatment Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-7I14407

Wed May 14 00:00:00 UTC 2025

Add to Cart

Global Anemia Gene Detection Kits Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-2Y14897

Tue May 13 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Hemophilia AAV Gene Therapy Market Research Report 2024

Published Date: November 2024

Report Code: QYRE-Auto-12Z18627

Global Hemophilia AAV Gene Therapy Market Research Report 2024

FEATURED COMPANIES

Hemophilia AAV Gene Therapy Market Size

Hemophilia AAV Gene Therapy Market

Scope of Hemophilia AAV Gene Therapy Market Report

Chapter Outline

FAQ for this report

How fast is Hemophilia AAV Gene Therapy Market growing?

What is the Hemophilia AAV Gene Therapy Market size in 2030?

Who are the main players in the Hemophilia AAV Gene Therapy Market report?

What are the Application segmentation covered in the Hemophilia AAV Gene Therapy Market report?

What are the Type segmentation covered in the Hemophilia AAV Gene Therapy Market report?

FEATURED COMPANIES

RELATED REPORTS